Cited by — Abstract No: 595 INDIVIDUALIZED TREATMENT EFFECTS OF FINERENONE VERSUS SPIRONOLACTONE IN STAGES 2-4 CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Abstract No: 595 INDIVIDUALIZED TREATMENT EFFECTS OF FINERENONE VERSUS SPIRONOLACTONE IN STAGES 2-4 CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME.
No admitted local citation edges point to this work yet.
